APA (7th ed.) Citation

Kevin Y. Heo, B., Rahul K. Goel, M., Andrew Fuqua, B., Jeffrey S. Holmes, M., Brian T. Muffly, M., Greg A. Erens, M., . . . Ajay Premkumar, M. Glucagon-Like Peptide-1 Receptor Agonist Use is Not Associated With Increased Complications After Total Knee Arthroplasty in Patients With Type-2 Diabetes. Elsevier.

Chicago Style (17th ed.) Citation

Kevin Y. Heo, BS, MD Rahul K. Goel, BS Andrew Fuqua, MD Jeffrey S. Holmes, MD Brian T. Muffly, MD Greg A. Erens, MD Jacob M. Wilson, and MD Ajay Premkumar. Glucagon-Like Peptide-1 Receptor Agonist Use Is Not Associated With Increased Complications After Total Knee Arthroplasty in Patients With Type-2 Diabetes. Elsevier.

MLA (9th ed.) Citation

Kevin Y. Heo, BS, et al. Glucagon-Like Peptide-1 Receptor Agonist Use Is Not Associated With Increased Complications After Total Knee Arthroplasty in Patients With Type-2 Diabetes. Elsevier.